Skip to main content
Equibles

TWO SIGMA INVESTMENTS, LP

Position in OCGN — Ocugen, Inc.

CIK 1179392 NEW YORK, NY
Back to OCGN Full portfolio

Position in OCGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,412,173
-$662,647 QoQ
Shares Held
2,230,179
-0.9% QoQ
Ownership
0.658%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 147 holders
Holding Since
Jun 2020
14 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in OCGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TWO SIGMA INVESTMENTS, LP holds $7,283,390,440 across 343 Biotechnology names. OCGN ranks #132 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALNY
Alnylam Pharmaceuticals, Inc.
 1,875,937 $564,713,315
2 MRNA
Moderna, Inc.
 7,193,530 $503,762,905
3 IONS
Ionis Pharmaceuticals Inc
 6,252,342 $495,748,197
4 REGN
Regeneron Pharmaceuticals, Inc.
 656,124 $409,119,558
5 BBIO
BridgeBio Pharma, Inc.
 4,722,185 $351,708,338
6 EXEL
Exelixis, Inc.
 4,209,861 $229,058,537
7 INCY
Incyte Corp
 2,003,559 $227,123,448
8 ARGX
Argenx SE
 185,638 $172,229,367

All Filings in OCGN

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,412,173 2,230,179
2026-03-31 $4,074,820 2,251,282
2025-12-31 $916,038 678,547
2025-09-30 $119,133 73,088
2024-12-31 $257,434 319,795
2024-09-30 $360,808 363,718
2024-06-30 $563,398 363,483
2024-03-31 $1,682,653 1,026,008
2023-12-31 $90,449 157,304
2023-09-30 $53,832 134,582
2023-06-30 $29,562 54,443
2022-12-31 $540,030 415,408
2022-09-30 $244,353 137,277
2020-06-30 $13,728 62,404